000			01592 a2200421 4500
005			20250516211933.0
264		0	_c20150910
008			201509s 0 0 eng d
022			_a1098-6596
024	7		_a10.1128/AAC.02981-14 _2doi
040			_aNLM _beng _cNLM
100	1		_aDutta, Noton K
245	0	0	_aReduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis. _h[electronic resource]
260			_bAntimicrobial agents and chemotherapy _cJul 2014
300			_a4048-53 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAntipsychotic Agents _xadverse effects
650	0	4	_aAntitubercular Agents
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Repositioning
650	0	4	_aDrug Resistance, Multiple, Bacterial
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aIsoniazid _xtherapeutic use
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMycobacterium tuberculosis _xdrug effects
650	0	4	_aRifampin _xtherapeutic use
650	0	4	_aThioridazine _xadverse effects
650	0	4	_aTuberculosis, Multidrug-Resistant _xdrug therapy
650	0	4	_aTuberculosis, Pulmonary _xdrug therapy
700	1		_aPinn, Michael L
700	1		_aKarakousis, Petros C
773	0		_tAntimicrobial agents and chemotherapy _gvol. 58 _gno. 7 _gp. 4048-53
856	4	0	_uhttps://doi.org/10.1128/AAC.02981-14 _zAvailable from publisher's website
999			_c23797779 _d23797779